Deals
China Gewang Biotechnology Raises $5M at 18% Discount
|
China Gewang Biotechnology (OTC:CGWB) announced that it has raised $5,473,200 in a Common Stock transaction pursuant to Regulation S.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/56/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
China Gewang Biotechnology (OTC:CGWB) announced that it has raised $5,473,200 in a Common Stock transaction pursuant to Regulation S.
Lixte Biotechnology Holdings (OTC:LIXT) announced that it has raised $1,750,000 in a Convertible Preferred Stock transaction.
Makemytrip Limited (NASDAQ GS:MMYT) announced that it has raised $180,000,000 in a Convertible Notes transaction.
Imprimis Pharmaceuticals (NASDAQ CM:IMMY) announced that it has raised $3,000,000 in a Convertible Senior Secured Notes transaction.